cbdMD, Inc. (YCBD)

Market Cap	5.13M -37.0%
Revenue (ttm)	19.98M +2.0%
Net Income	-3.11M
EPS	-0.36
Shares Out	10.50M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	158,727
Open	0.5100
Previous Close	0.5000
Day's Range	0.4701 - 0.5100
52-Week Range	0.4701 - 2.5600
Beta	2.13
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 13, 2026

About YCBD

cbdMD, Inc. produces and distributes various cannabidiol (CBD) products in the United States and internationally. The company owns and operates various consumer hemp-based CBD brands. Its cbdMD brand products include oils, gummies, capsules, soft-gels, topicals, functional formulations, and hemp-derived compliant Delta-9 THC products. It also provides products for dogs and cats, including tinctures, chews, and topicals under the Paw CBD brand name; non-cannabinoid functional ingredients, such as functional mushrooms under the ATRx brand; and he...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2015
• Employees: 42
• Stock Exchange: NYSEAMERICAN
• Ticker Symbol: YCBD
• Website: https://www.cbdmd.com

Financial Performance

In fiscal year 2025, cbdMD's revenue was $19.19 million, a decrease of -1.50% compared to the previous year's $19.48 million. Losses were -$4.38 million, -43.21% less than in 2024.

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Jul 30, 2026

Data Sources Report a data error